EXPD
48
-5
CVX
46
8
MAT
41
-4
DUK
64
7
PYPL
56
-4
HAL
62
-2
PNW
70
3
AMGN
31
-16
ORLY
66
4
EXPE
93
2
VFC
50
-2
GME
70
2
PLD
56
-5
MMM
42
5
UAL
83
-2
PSX
50
3
GOOG
57
2
WU
34
-2
BEN
48
-4
PGR
68
3
EXPD
48
-5
CVX
46
8
MAT
41
-4
DUK
64
7
PYPL
56
-4
HAL
62
-2
PNW
70
3
AMGN
31
-16
ORLY
66
4
EXPE
93
2
VFC
50
-2
GME
70
2
PLD
56
-5
MMM
42
5
UAL
83
-2
PSX
50
3
GOOG
57
2
WU
34
-2
BEN
48
-4
PGR
68
3
Financhill
Back

Evolution AB Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
38

EVVTY
Evolution AB

Last Price:
90.66
Seasonality Move:
24%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.74
Seasonality Move:
14.88%
Sell
38
Evolution AB (EVVTY) is a Sell

Is Evolution AB a Buy, Sell or Hold?

  • The current Evolution AB [EVVTY] share price is $89.78. The Score for EVVTY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • EVVTY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVVTY Stock Price Chart

What is Evolution AB's stock price today?

  • The Evolution AB share price today is $89.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVVTY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EVVTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.31 Sell
Relative Strength Index (14 RSI): 44.02 Sell
Chaikin Money Flow: -36995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.84 - 95.66) Sell
Bollinger Bands (100): (91.36 - 102.5) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

EVVTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.95 Sell
20-day SMA: 91.11 Sell
50-day SMA: 93.83 Sell
200-day SMA: 106.98 Sell
8-day EMA: 89.88 Sell
20-day EMA: 91 Sell
50-day EMA: 93.49 Sell
200-day EMA: 102.37 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Evolution AB Earnings Growth & EVVTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Evolution AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):